Waters [WAT] vs Idexx Laboratories [IDXX] Detailed Stock Comparison

Waters

NYSE
Loading...

Idexx Laboratories

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Waters wins in 8 metrics, Idexx Laboratories wins in 11 metrics, with 0 ties. Idexx Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricWatersIdexx LaboratoriesBetter
P/E Ratio (TTM)29.6652.42Waters
Price-to-Book Ratio9.0534.68Waters
Debt-to-Equity Ratio73.8684.81Waters
PEG Ratio11.921.07Idexx Laboratories
EV/EBITDA19.6837.03Waters
Profit Margin (TTM)21.71%24.41%Idexx Laboratories
Operating Margin (TTM)26.22%33.62%Idexx Laboratories
EBITDA Margin (TTM)26.22%33.62%Idexx Laboratories
Return on Equity37.03%64.87%Idexx Laboratories
Return on Assets (TTM)11.70%23.26%Idexx Laboratories
Free Cash Flow (TTM)$619.64M$798.08MIdexx Laboratories
1-Year Return-8.48%31.81%Idexx Laboratories
Price-to-Sales Ratio (TTM)6.4212.51Waters
Enterprise Value$20.78B$51.57BIdexx Laboratories
EV/Revenue Ratio6.8212.77Waters
Gross Profit Margin (TTM)58.33%62.62%Idexx Laboratories
Revenue per Share (TTM)$51$50Waters
Earnings per Share (Diluted)$11.07$12.04Idexx Laboratories
Beta (Stock Volatility)1.041.58Waters
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Waters vs Idexx Laboratories Stock Performance Analysis

Loading Price Chart...

Waters
Idexx Laboratories
Waters Stock Overview | Idexx Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Waters-0.23%13.19%5.90%-5.51%0.56%-11.04%
Idexx Laboratories-0.54%-0.44%-3.84%15.07%65.65%53.55%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Waters-8.48%20.36%55.20%170.78%354.65%795.63%
Idexx Laboratories31.81%93.38%48.15%751.80%1,915.99%3,848.30%

News Based Sentiment: Waters vs Idexx Laboratories

Waters

News based Sentiment: POSITIVE

October was a pivotal month for Waters Corporation, marked by strong financial results, a transformative merger announcement, and continued innovation. These developments collectively position the company for significant growth and leadership in the life sciences sector, making it a highly noteworthy period for investors.

View Waters News Sentiment Analysis

Idexx Laboratories

News based Sentiment: MIXED

IDEXX reported impressive Q2 results and raised guidance, indicating strong performance. However, a pending regulatory review, mixed adoption of a key product, and insider selling introduce uncertainty, creating a mixed investment narrative. The combination of positive and negative developments warrants a cautious yet optimistic outlook.

View Idexx Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Waters vs Idexx Laboratories

MetricWATIDXX
Market Information
Market Cap i$19.70B$50.50B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i682,420397,460
90 Day Avg. Volume i685,287414,530
Last Close$327.62$627.78
52 Week Range$275.05 - $423.56$356.14 - $688.12
% from 52W High-22.65%-8.77%
All-Time High$428.22 (Sep 06, 2021)$706.95 (Jul 26, 2021)
% from All-Time High-23.49%-11.20%
Growth Metrics
Quarterly Revenue Growth0.09%0.11%
Quarterly Earnings Growth0.03%0.45%
Financial Health
Profit Margin (TTM) i0.22%0.24%
Operating Margin (TTM) i0.26%0.34%
Return on Equity (TTM) i0.37%0.65%
Debt to Equity (MRQ) i73.8684.81
Cash & Liquidity
Book Value per Share (MRQ)$36.29$18.20
Cash per Share (MRQ)$6.17$2.06
Operating Cash Flow (TTM) i$745.41M$905.81M
Levered Free Cash Flow (TTM) i$465.32M$625.74M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Waters vs Idexx Laboratories

MetricWATIDXX
Price Ratios
P/E Ratio (TTM) i29.6652.42
Forward P/E i25.4052.78
PEG Ratio i11.921.07
Price to Sales (TTM) i6.4212.51
Price to Book (MRQ) i9.0534.68
Market Capitalization
Market Capitalization i$19.70B$50.50B
Enterprise Value i$20.78B$51.57B
Enterprise Value Metrics
Enterprise to Revenue i6.8212.77
Enterprise to EBITDA i19.6837.03
Risk & Other Metrics
Beta i1.041.58
Book Value per Share (MRQ) i$36.29$18.20

Financial Statements Comparison: Waters vs Idexx Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)WATIDXX
Revenue/Sales i$661.71M$998.43M
Cost of Goods Sold i$276.75M$375.05M
Gross Profit i$384.96M$623.38M
Research & Development i$46.62M$59.06M
Operating Income (EBIT) i$151.75M$316.53M
EBITDA i$206.53M$351.81M
Pre-Tax Income i$142.89M$310.08M
Income Tax i$21.51M$67.41M
Net Income (Profit) i$121.38M$242.68M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)WATIDXX
Cash & Equivalents i$382.87M$163.97M
Total Current Assets i$1.74B$1.32B
Total Current Liabilities i$960.97M$1.14B
Long-Term Debt i$1.41B$546.80M
Total Shareholders Equity i$1.96B$1.45B
Retained Earnings i$9.91B$5.58B
Property, Plant & Equipment i$721.04M$833.62M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)WATIDXX
Operating Cash Flow i$259.55M$235.07M
Capital Expenditures i$-25.74M$-30.03M
Free Cash Flow i$233.81M$207.94M
Debt Repayment i$-170.00MN/A
Common Stock Repurchase i$-13.93M$-400.89M

Short Interest & Institutional Ownership Analysis

MetricWATIDXX
Shares Short i2.29M2.12M
Short Ratio i3.925.41
Short % of Float i0.05%0.03%
Average Daily Volume (10 Day) i682,420397,460
Average Daily Volume (90 Day) i685,287414,530
Shares Outstanding i59.39M81.60M
Float Shares i59.40M79.12M
% Held by Insiders i0.00%0.01%
% Held by Institutions i1.00%0.97%

Dividend Analysis & Yield Comparison: Waters vs Idexx Laboratories

MetricWATIDXX
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A